Provides further evidence of the clinical validity and utility of personalised medicine, with special emphasis on the prevention of chronic diseases Represents the five main domains that focus on prevention in personalised medicine that need to be taken into account for an appropriate evaluation of genetic/genomic technologies Includes evidence-based recommendations that add to or summarise the available literature by giving an up-to-date perspective on personalised medicine Offers a comprehensive perspective from a multi-professional, multi-disciplinary team of scientists Features the recommendations of the Personalized pREvention of Chronic Disease (PRECeDI) Consortium

Autorentext

Stefania Boccia, PhD, DSc, MS, is Full professor of Hygiene, Preventive Medicine and Public Health at Università Cattolica del Sacro Cuore (UCSC) in Rome, Italy. She is the Director of the Section of Hygiene of the Department of Health Science and Public Health of UCSC and President of the Public Health Epidemiology Section of European Public Health Association (EUPHA). A Biologist by training and Specialist in Clinical Pathology, she obtained a Master of Science in Epidemiology and Biostatistics and a Doctor of Science and PhD in Genetic Epidemiology at the Erasmus MC in Rotterdam, the Netherlands. From 2016 to 2018 she was Adjunct Professor at Mount Sinai Medical School in New York, NY, USA. In 2018 she founded the spin-off "Vihtali srl" (Value In Health Technology and Academy for Leadership & Innovation) at UCSC. She currently coordinates the project titled "European network staff eXchange for integrAting precision health in the health Care sysTems" (ExACT) funded by the European Commission (EC) within the H2020 Marie-Slodowska Curie projects (MSCA-RISE). She is currently partner of several EU-funded projects; among them is  "Integrating China in the International Consortium for Personalised Medicine" (IC2PerMed, CSA) as a member of the Coordinating group. She is author and co-author of 216 scientific publications; her h-index (Scopus) is 37 and citation count is 5350.
Róza Ádány, MD, PhD, DSc, is a medical doctor with specialization in the field of preventive medicine and public health. She is Professor of public health at the University of Debrecen, Hungary; founding Dean of the Faculty of Public Health; leader of the Public Health Research Group funded by the Hungarian Academy of Sciences; head of the WHO Collaborating Centre on Vulnerability and Health; and President of the Public Health Genomics Section of the European Public Health Association. She also acts as president of the Hungarian Associationof Public Health Training and Research Institutes, chief editor of the journal 'Népegészségügy' (Public Health), editorial member of the European Journal of Public Health, associate editor of the Frontiers in Public Health journal, and Vice-Chair of the European Advisory Committee on Health Research for WHO European Region. She was chairperson of the Association of Schools of Public Health in the European Region (ASPHER) between 2001-2003. She contributed as expert adviser to the development of the revised version of the Health for All and the draft of the Health 2020 strategies of the WHO Europe. She is author and co-author of 237 scientific publications; her h-index (Scopus) is 33 and citation count (Scopus) is 4634. She received several prestigious Hungarian and international awards in acknowledgement of her work.
Paolo Villari, MD, MPH, is Full professor of Hygiene and, since 2015, is Director of the Department of Public Health and Infectious Diseases at Sapienza University of Rome, Italy, where he also is Member of the Academic Senate. A graduate in Medicine and Surgery and Specialist in Hygiene and Preventive Medicine, he obtained the Master's Degree in Public Health at Harvard University. As former President of the Epidemiology Section of the European Public Health Association (EUPHA) in the years 2004-2006 and national delegate for Italy to the Federation of European Academies of Medicine (FEAM) from 2007 to 2013, he was Deputy Secretary General of the FEAM from 2010 to 2013. A member of the Scientific Committee at the Ministry of Health, Directorate General of Health Planning, from 2011 to 2013, he is currently Chairman of the National Committee for the Verification of measles and rubella elimination. He is responsible for international and national research projects, funded by the University, Ministry of Health, Ministry of University, EU in the fields of epidemiology of infectious diseases, health management and health services research. He is author and co-author of 165 publications (Scopus); his h-index (Scopus) is 32 and citation count (Scopus) is 3096.
Martina C. Cornel, MD, PhD, is professor of community genetics and public health genomics at the Amsterdam University Medical Centers, location VUMC, in the Department of Clinical Genetics, Section of Community Genetics, and the Amsterdam Public Health Research Institute, in The Netherlands. She is a physician and epidemiologist. After 2000 she mainly worked on the responsible implementation of genetic testing and screening. She is vice chair of the Netherlands patients' umbrella organization for rare and genetic diseases (VSOP: https://vsop.nl/). She is co-chair of the Public and Professional Policy Committee of the European Society of Human Genetics. She is a member of the Netherlands Health Council and two of its standing Committees (Population Screening and Advisory Council). She is chair of the Netherlands ProgramCommittee Neonatal Heelprick Screening. She is Editor-in-Chief of the Journal of Community Genetics. She is author and co-author of 288 publications (Scopus); her h-index (Scopus) is 37 and citation count (Web of Science Core collection) is 3891.
Corrado De Vito, MD, PhD, is an epidemiologist and Associate professor of Hygiene at the Department of Public Health and Infectious Diseases at Sapienza University of Rome, Italy. Since 2020 he is the Director of the Residency of Hygiene and Preventive Medicine of Sapienza University of Rome. Corrado De Vito graduated in Medicine and Surgery, and obtained a PhD in Infectious Diseases, Microbiology and Public Health at Sapienza University of Rome. He is principal investigator or partner of several national and international projects in the fields of vaccines and vaccination, chronic care models and public health genomics. In the latter field he is partner of the "European network staff eXchange for integrAting precision health in the health Care sysTems" (ExACT) funded by the European Commission (EC) within the H2020 Marie-Slodowska Curie projects (MSCA-RISE). He is author and co-author of 100 publications (Scopus); his h-index (Scopus) is 20 and citation count (Scopus) is 1375.
Roberta Pastorino, PhD, is a post-doc fellow at the Department of Woman and Child Health and Public Health-Public Health Area at Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome, Italy. She is a Bioengineer with a PhD in Biostatistics and a Master in Genetic Epidemiology. She is Vice-President of the Public Health Genomics Section of the European Public Health Association (EUPHA) and currently Project Manager of the project titled "European network staff eXchange for integrAting precision health in the health Care sysTems" (ExACT) funded by the European Commission (EC) within the H2020 Marie-Slodowska Curie projects (MSCA-RISE). She is author and co-author of 66 scientific publications; her h-index (Scopus) is 16 and citation count is 614.

Inhalt

Introduction (Boccia).- 1. Chapter 1: Identification of biomarkers for the prevention of chronic disease (Editors: Adany, Boccia).- 2. Chapter 2: Evaluation of predictive genomic applications (Editor: Villari). -3. Chapter 3: Ethico-legal and policy issues surrounding personalised medicine (Editor: Sandor).- olicy issue, with a focus…